| Identification | Back Directory | [Name]
Benzoic acid, 2-(1H-indol-6-yl)-3-[2-[4-[[(tetrahydro-2H-pyran-4-yl)oxy]methyl]phenyl]ethynyl]- | [CAS]
2044520-06-9 | [Synonyms]
VK-2019 2-(1H-Indol-6-yl)-3-((4-(((tetrahydro-2H-pyran-4-yl)oxy)methyl)phenyl)ethynyl)benzoic acid Benzoic acid, 2-(1H-indol-6-yl)-3-[2-[4-[[(tetrahydro-2H-pyran-4-yl)oxy]methyl]phenyl]ethynyl]- | [Molecular Formula]
C29H25NO4 | [MOL File]
2044520-06-9.mol | [Molecular Weight]
451.51 |
| Chemical Properties | Back Directory | [Boiling point ]
689.9±55.0 °C(Predicted) | [density ]
1.33±0.1 g/cm3(Predicted) | [form ]
Solid | [pka]
3.69±0.36(Predicted) | [color ]
Light yellow to yellow |
| Hazard Information | Back Directory | [Uses]
VK-2019 is useful for the the treatment of diseases caused by latent Epstein-Barr Virus (EBV) infection and/or lytic EBV infection. |
|
| Company Name: |
NewCan Biotech Limited
|
| Telephone: |
+86-0571-86912261 +86-15658003402 |
| Website: |
https://www.newcanbio.com/ |
| Company Name: |
Bide Pharmatech Ltd.
|
| Telephone: |
400-1647117 13681763483 |
| Website: |
https://www.bidepharm.com/ |
|